Preferred Name |
Repaglinide |
|
Synonyms |
|
|
Definitions |
A nonsulfonylurea insulin secretagogue belonging to the melgitinide class with hypoglycemic activity. Repaglinide is rapidly absorbed and has a rapid onset and short duration of action. This agent is metabolized in the liver by CYP2C8 and CYP3A4 and its metabolites are excreted in the bile. Repaglinide has a half-life of one hour. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C47703 |
|
CAS_Registry |
135062-02-1 |
|
Chemical_Formula |
C27H36N2O4 |
|
code |
C47703 |
|
Contributing_Source |
CTRP FDA |
|
definition |
A nonsulfonylurea insulin secretagogue belonging to the melgitinide class with hypoglycemic activity. Repaglinide is rapidly absorbed and has a rapid onset and short duration of action. This agent is metabolized in the liver by CYP2C8 and CYP3A4 and its metabolites are excreted in the bile. Repaglinide has a half-life of one hour. |
|
Display_Name |
Repaglinide |
|
FDA_UNII_Code |
668Z8C33LU |
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
label |
Repaglinide |
|
Legacy Concept Name |
Repaglinide |
|
NCI_Drug_Dictionary_ID |
775334 |
|
PDQ_Closed_Trial_Search_ID |
775334 |
|
PDQ_Open_Trial_Search_ID |
775334 |
|
Preferred_Name |
Repaglinide |
|
prefixIRI |
NCIT:C47703 |
|
prefLabel |
Repaglinide |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0246689 |
|
subClassOf |